Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ronojoy
Sen Gupta & Joohong Ahnn. (2003) Cadmium‐induced gene expression is regulated by MTF‐1, a key metal‐responsive transcription factor. Korean Journal of Biological Sciences 7:3, pages 173-186.
Read now
Read now
R. ZANIER. (1996) Topoisomerase I activity and cellular response to radiation in Chinese hamster cells. International Journal of Radiation Biology 70:3, pages 251-259.
Read now
Read now
I. Szumiel, I. Buraczewska, I. Gradzka & A. Gasinska. (1995) Effects of Topoisomerase I-targeted Drugs on Radiation Response of L5178Y Sublines Differentially Radiation and Drug Sensitive. International Journal of Radiation Biology 67:4, pages 441-448.
Read now
Read now
C.E. Ng, A.M. Bussey & G.P. Raaphorst. (1994) Inhibition of Potentially Lethal and Sublethal Damage Repair by Camptothecin and Etoposide in Human Melanoma Cell Lines. International Journal of Radiation Biology 66:1, pages 49-57.
Read now
Read now
Articles from other publishers (18)
Yan Wang, Phillip R. Musich, Kui Cui, Yue Zou & Meng-Yang Zhu. (2015) Neurotoxin-Induced DNA Damage is Persistent in SH-SY5Y Cells and LC Neurons. Neurotoxicity Research 27:4, pages 368-383.
Crossref
Crossref
Daniel Sagan, Simone Mörtl, Irene Müller, Friederike Eckardt-Schupp & Hedda Eichholtz-Wirth. (2007) Enhanced CD95-mediated apoptosis contributes to radiation hypersensitivity of NBS lymphoblasts. Apoptosis 12:4, pages 753-767.
Crossref
Crossref
Christian Mielke, Morten O. Christensen, Hans Ullrich Barthelmes & Fritz Boege. (2004) Enhanced Processing of UVA-irradiated DNA by Human Topoisomerase II in Living Cells. Journal of Biological Chemistry 279:20, pages 20559-20562.
Crossref
Crossref
Jae-Sung Kim, George P. Amorino, Hongryull Pyo, Qianwen Cao & Hak Choy. (2002) Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells. Radiotherapy and Oncology 62:1, pages 61-67.
Crossref
Crossref
Kevin K. Anbari, Lynne A. Ierardi-Curto, Jeff S. Silber, Naohiro Asada, Nancy Spinner, Elaine H. Zackai, Jean Belasco, Jennifer Dowhanick Morrissette & John P. Dormans. (2000) Two Primary Osteosarcomas in a Patient With Rothmund-Thomson Syndrome. Clinical Orthopaedics and Related Research 378, pages 213-223.
Crossref
Crossref
George P Amorino, Sherri K Hercules, Peter J Mohr, Hongryull Pyo & Hak Choy. (2000) Preclinical evaluation of the orally active camptothecin analog, RFS-2000 (9-nitro-20(S)-camptothecin) as a radiation enhancer. International Journal of Radiation Oncology*Biology*Physics 47:2, pages 503-509.
Crossref
Crossref
Vivian Hsiu-Chuan Liao & Jonathan H. Freedman. (1998) Cadmium-regulated Genes from the NematodeCaenorhabditis elegans. Journal of Biological Chemistry 273:48, pages 31962-31970.
Crossref
Crossref
Manuela López-Baena, Santiago Mateos, Joaquı́n Piñero, Trinidad Ortiz & Felipe Cortés. (1998) Enhanced sensitivity to topoisomerase inhibitors in synchronous CHO cells pre-treated with 5-azacytidine. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 421:1, pages 109-116.
Crossref
Crossref
Barry Goz & Kenneth F Bastow. (1997) A possible role for topoisomerase II in cell death and N-phosphonoacetyl-l-aspartate-resistance frequency and its enhancement by 1-β-d-arabinofuranosyl cytosine and 5-fluoro-2′-deoxyuridine. Mutation Research/DNA Repair 384:2, pages 89-106.
Crossref
Crossref
Li-Jun Mi, Lai-No Chiu, Evan Mahl & Robert J. Boorstein. (1995) Toxicity of camptothecin to Chinese hamster cells containing 5-hydroxymethyl-2′-deoxyuridine in their DNA. Mutation Research/DNA Repair 336:3, pages 293-305.
Crossref
Crossref
M.J. McKay, G.J. Mann, D.A. McDonald, S. Jones & R.F. Kefford. (1994) Isolation and preliminary characterisation of an X-ray-sensitive mamamalian mutant cell line (WMXRS-1). Mutation Research/DNA Repair 314:3, pages 261-271.
Crossref
Crossref
Gillian M. Duchesne. (1994) Fundamental bases of combined therapy in lung cancer: cell resistance to chemotherapy and radiotherapy. Lung Cancer 10, pages S67-S72.
Crossref
Crossref
William T. Beck, Mary K. Danks, Judith S. Wolverton, Mei Chen, Bernd Granzen, Ryungsa Kim & D. Parker Suttle. 1994. DNA Topoisomerases: Topoisomerase-Targeting Drugs. DNA Topoisomerases: Topoisomerase-Targeting Drugs
145
169
.
G. Del Bino, S. Bruno, P. N. Yi & Z. Darzynkiewicz. (2008) Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation. Cell Proliferation 25:6, pages 537-548.
Crossref
Crossref
William D. Wright & Joseph L. Roti Roti. (1992) Resolution of DNA Topoisomerase II by two-dimensional polyacrylamide gel electrophoresis and western blotting. Analytical Biochemistry 204:1, pages 124-130.
Crossref
Crossref
Gillian Ross & Robert Brown. (1992) The role of DNA repair processes in determining response to cancer therapy. European Journal of Cancer 28:1, pages 281-285.
Crossref
Crossref
Fumihiro Oshita, Yasuhiro Fujiwara & Nagahiro Saijo. (1992) Radiation sensitivities in various anticancer-drug-resistant human lung cancer cell lines and mechanism of radiation cross-resistance in a cisplatin-resistant cell line. Journal of Cancer Research and Clinical Oncology 119:1, pages 28-34.
Crossref
Crossref
A.H. Corbett, E.L. Zechiedrich, R.S. Lloyd & N. Osheroff. (1991) Inhibition of eukaryotic topoisomerase II by ultraviolet-induced cyclobutane pyrimidine dimers.. Journal of Biological Chemistry 266:29, pages 19666-19671.
Crossref
Crossref